Wenbin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wenbin Zhang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Yimei Hu
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China
5 shared publications Feilong Lu
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
4 shared publicationsHao Song
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
4 shared publicationsYulin Ma
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
4 shared publicationsZhaoxi Yang
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
3 shared publicationsXiaoming Du
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
2 shared publications
Latest Publications
- Open Access
Clinical effects and safety of proximal femur bionic nail versus proximal femoral nail anti-rotation or InterTAN for the treatment of intertrochanteric femoral fracture: a systematic review and meta-analysis
Objective: To compare the clinical effects and safety of the proximal femur bionic nail (PFBN) with those of proximal femoral nail anti-rotation (PFNA) and InterTAN for the treatment of intertrochanteric femoral fracture (IFF). Methods: Studies comparing the clinical efficacy of PFBN with that of PFNA and InterTAN in the treatment of IFF published before 16 December 2025 in the PubMed, Embase, Web of Science, Cochrane, CNKI, Wanfang, and VIP databases were retrieved. After the research data were extracted, Review Manager 5.4 (RevMan 5.4 ) was used for data analysis. Results: A total of 15 studies involving 990 patients were included. The meta-analysis results indicated that the PFBN group had advantages over the control group in terms of the postoperative partial and full weight-bearing time, fracture healing time, fracture reduction quality, hospital stay, postoperative Harris score, intraoperative fluoroscopy time and postoperative complication rate (partial weight-bearing time: standardized mean difference ( SMD ) = −3.49, 95% confidence interval (CI) [−4.47 to −2.52], P < 0.00001; full weight-bearing time: SMD = −1.78, 95% CI [−2.86 to −0.70], P = 0.001; fracture healing time: SMD = −0.61, 95% CI −[0.86 to −0.37], P < 0.00001; fracture reduction quality: relative risk ( RR ) = 1.07, 95% CI [1.01∼1.13], P = 0.02; hospital stay: SMD = −0.44, 95% CI [−0.81 to −0.08], P = 0.02; postoperative complication rate: RR = 0.36, 95% CI [0.22∼0.59], P < 0.0001; postoperative Harris score: SMD = 0.32, 95% CI [0.04∼0.60], P = 0.02; intraoperative fluoroscopy time: SMD = 0.76, 95% CI [0.10∼1.42], P = 0.02). There was no significant difference between the two groups in terms of intraoperative blood loss, operation duration, postoperative hip range of motion, postoperative VAS score, or incision length (intraoperative blood loss: SMD = −0.30, 95% CI [−0.81∼0.21], P = 0.25; operation duration: SMD = 0.41, 95% CI [−0.03∼0.85], P = 0.07; postoperative flexion and extension motion: SMD = 0.28, 95% CI [−0.18∼0.73], P = 0.23; postoperative rotational motion: SMD = 0.20, 95% CI [−0.25∼0.66], P = 0.38; incision length: SMD = 0.23, 95% CI [−0.44∼0.89], P = 0.50; postoperative VAS score: SMD = −0.29, 95% CI [−0.82∼0.23], P = 0.27). Conclusion: For the treatment of IFF , the PFBN is more effective and has a lower risk than the PFNA and InterTAN.
Open AccessClinical effects and safety of proximal femur bionic nail versus proximal femoral nail anti-rotation or InterTAN for the treatment of intertrochanteric femoral fracture: a systematic review and meta-analysis
Objective: To compare the clinical effects and safety of the proximal femur bionic nail (PFBN) with those of proximal femoral nail anti-rotation (PFNA) and InterTAN for the treatment of intertrochanteric femoral fracture (IFF). Methods: Studies comparing the clinical efficacy of PFBN with that of PFNA and InterTAN in the treatment of IFF published before 16 December 2025 in the PubMed, Embase, Web of Science, Cochrane, CNKI, Wanfang, and VIP databases were retrieved. After the research data were extracted, Review Manager 5.4 (RevMan 5.4 ) was used for data analysis. Results: A total of 15 studies involving 990 patients were included. The meta-analysis results indicated that the PFBN group had advantages over the control group in terms of the postoperative partial and full weight-bearing time, fracture healing time, fracture reduction quality, hospital stay, postoperative Harris score, intraoperative fluoroscopy time and postoperative complication rate (partial weight-bearing time: standardized mean difference ( SMD ) = −3.49, 95% confidence interval (CI) [−4.47 to −2.52], P < 0.00001; full weight-bearing time: SMD = −1.78, 95% CI [−2.86 to −0.70], P = 0.001; fracture healing time: SMD = −0.61, 95% CI −[0.86 to −0.37], P < 0.00001; fracture reduction quality: relative risk ( RR ) = 1.07, 95% CI [1.01∼1.13], P = 0.02; hospital stay: SMD = −0.44, 95% CI [−0.81 to −0.08], P = 0.02; postoperative complication rate: RR = 0.36, 95% CI [0.22∼0.59], P < 0.0001; postoperative Harris score: SMD = 0.32, 95% CI [0.04∼0.60], P = 0.02; intraoperative fluoroscopy time: SMD = 0.76, 95% CI [0.10∼1.42], P = 0.02). There was no significant difference between the two groups in terms of intraoperative blood loss, operation duration, postoperative hip range of motion, postoperative VAS score, or incision length (intraoperative blood loss: SMD = −0.30, 95% CI [−0.81∼0.21], P = 0.25; operation duration: SMD = 0.41, 95% CI [−0.03∼0.85], P = 0.07; postoperative flexion and extension motion: SMD = 0.28, 95% CI [−0.18∼0.73], P = 0.23; postoperative rotational motion: SMD = 0.20, 95% CI [−0.25∼0.66], P = 0.38; incision length: SMD = 0.23, 95% CI [−0.44∼0.89], P = 0.50; postoperative VAS score: SMD = −0.29, 95% CI [−0.82∼0.23], P = 0.27). Conclusion: For the treatment of IFF , the PFBN is more effective and has a lower risk than the PFNA and InterTAN.
- 20 December 2025
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 22 (2) , 989-1006
Significance of Stem Cell-Derived Exosomes in Femoral Head Necrosis: A Systematic Review and Meta-Analysis of Preclinical Studies
Background Steroid-induced osteonecrosis of the femoral head (SONFH) is a progressive and refractory orthopedic disorder characterized by deterioration of the subchondral bone microstructure and eventual femoral head collapse, leading to hip joint dysfunction. Current therapeutic strategies offer limited efficacy and fail to reverse the necrotic process, with approximately 70% of patients eventually requiring total hip arthroplasty. Therefore, developing novel treatments capable of halting disease progression and promoting bone repair is crucial for addressing this clinical challenge. Exosomes, bioactive nanovesicles that regulate apoptosis, angiogenesis, and inflammation, represent a promising regenerative modality. In particular, stem cell-derived exosomes are considered to play a key role in the treatment of SONFH by promoting osteogenesis and angiogenesis and modulating inflammatory responses. However, the efficacy and mechanisms underlying exosome-based therapy for SONFH have not been systematically evaluated. A comprehensive synthesis of current evidence is urgently needed to inform future clinical translation. Purpose By synthesizing preclinical evidence, this study explored the mechanism and therapeutic potential of stem cell-derived exosomes in SONFH and identified key methodological limitations to provide a roadmap for future research. Study Design Systematic review and meta-analysis. Methods A comprehensive literature search was conducted in PubMed, Web of Science, the Cochrane Library, and Embase for preclinical studies published from database inception until August 2025, with a focus on exosome-based therapy for osteonecrosis of the femoral head. Studies meeting the predefined inclusion criteria were rigorously selected and assessed for methodological quality, and relevant data were extracted. All the statistical analyses were performed via Review Manager (RevMan) version 5.4 software. Results A total of 12 studies were included, all of which involved rat models of SONFH. The results of the meta-analysis revealed that exosome intervention significantly increased bone mineral density (BMD), thickness of trabecula, percentage of bone mass, the number of trabecula, vascular length, vascular volume and vascular area and reduced trabecular bone dissociation. Conclusion Exosomes rescue SONFH through multiple pathways. By promoting angiogenesis and osteogenesis, they effectively reverse the core pathological process of femoral head necrosis.
- 20 December 2025
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 22 (2) , 989-1006
Significance of Stem Cell-Derived Exosomes in Femoral Head Necrosis: A Systematic Review and Meta-Analysis of Preclinical Studies
Background Steroid-induced osteonecrosis of the femoral head (SONFH) is a progressive and refractory orthopedic disorder characterized by deterioration of the subchondral bone microstructure and eventual femoral head collapse, leading to hip joint dysfunction. Current therapeutic strategies offer limited efficacy and fail to reverse the necrotic process, with approximately 70% of patients eventually requiring total hip arthroplasty. Therefore, developing novel treatments capable of halting disease progression and promoting bone repair is crucial for addressing this clinical challenge. Exosomes, bioactive nanovesicles that regulate apoptosis, angiogenesis, and inflammation, represent a promising regenerative modality. In particular, stem cell-derived exosomes are considered to play a key role in the treatment of SONFH by promoting osteogenesis and angiogenesis and modulating inflammatory responses. However, the efficacy and mechanisms underlying exosome-based therapy for SONFH have not been systematically evaluated. A comprehensive synthesis of current evidence is urgently needed to inform future clinical translation. Purpose By synthesizing preclinical evidence, this study explored the mechanism and therapeutic potential of stem cell-derived exosomes in SONFH and identified key methodological limitations to provide a roadmap for future research. Study Design Systematic review and meta-analysis. Methods A comprehensive literature search was conducted in PubMed, Web of Science, the Cochrane Library, and Embase for preclinical studies published from database inception until August 2025, with a focus on exosome-based therapy for osteonecrosis of the femoral head. Studies meeting the predefined inclusion criteria were rigorously selected and assessed for methodological quality, and relevant data were extracted. All the statistical analyses were performed via Review Manager (RevMan) version 5.4 software. Results A total of 12 studies were included, all of which involved rat models of SONFH. The results of the meta-analysis revealed that exosome intervention significantly increased bone mineral density (BMD), thickness of trabecula, percentage of bone mass, the number of trabecula, vascular length, vascular volume and vascular area and reduced trabecular bone dissociation. Conclusion Exosomes rescue SONFH through multiple pathways. By promoting angiogenesis and osteogenesis, they effectively reverse the core pathological process of femoral head necrosis.
- Open Access
- 9 September 2025
- Published by Springer Nature in Research Square
Clinical effects and safety of proximal femur bionic nail versus proximal femoral nail anti-rotation and InterTAN for the treatment of intertrochanteric femoral fracture: a systematic review and meta-analysis
Objective To compare the clinical effects and safety of the proximal femur bionic nail (PFBN) with those of proximal femoral nail anti-rotation (PFNA) and InterTAN for the treatment of intertrochanteric femoral fracture (IFF). Methods Studies comparing the clinical efficacy of PFBN with that of PFNA and InterTAN in the treatment of IFF published before August 2024 in the PubMed, Embase, Web of Science, Cochrane, CNKI, Wanfang, and VIP databases were retrieved. After the research data were extracted, Review Manager 5.4 (RevMan 5.4) was used for data analysis. Results A total of 13 studies involving 825 patients were included. The meta-analysis results indicated that the PFBN group had advantages over the control group in terms of the postoperative partial and full weight-bearing time, fracture healing time, fracture reduction quality, hospital stay, visual analog scale (VAS) score, and postoperative complication rate (partial weight-bearing time: standardized mean difference (SMD) = -3.06, 95% confidence interval (CI) -4.02~-2.09, P < 0.00001; full weight-bearing time: SMD = -1.78, 95% CI -2.86~-0.70, P = 0.001; fracture healing time: SMD = -0.55, 95% CI -0.82~-0.28, P < 0.0001; fracture reduction quality: relative risk (RR) = 1.07, 95% CI 1.01 ~ 1.13, P = 0.02; hospital stay: SMD = -0.16, 95% CI -0.33 ~ 0.00, P = 0.05; postoperative VAS score: SMD = -0.54, 95% CI -0.90~-0.18, P = 0.003; postoperative complication rate: RR = 0.36, 95% CI 0.21 ~ 0.61, P = 0.0001). There was no significant difference between the two groups in terms of intraoperative blood loss, operation duration, postoperative hip range of motion, postoperative Harris score, intraoperative fluoroscopy time, or incision length (intraoperative blood loss: SMD = -0.57, 95% CI -1.16 ~ 0.02, P = 0.06; operation duration: SMD = 0.28, 95% CI -0.20 ~ 0.76, P = 0.26; postoperative flexion and extension motion: SMD = 0.28, 95% CI -0.18 ~ 0.73, P = 0.23; postoperative rotational motion: SMD = 0.20, 95% CI -0.25 ~ 0.66, P = 0.38; postoperative Harris score: SMD = 0.32, 95% CI 0.00 ~ 0.64, P = 0.05; intraoperative fluoroscopy time: SMD = 0.84, 95% CI -0.24 ~ 1.92, P = 0.13; incision length: SMD = 0.23, 95% CI -0.44 ~ 0.89, P = 0.50). Conclusion For the treatment of IFF, the PFBN is more effective and has a lower risk than the PFNA and InterTAN.
- 9 September 2025
- Published by Springer Nature in Research Square
Open AccessClinical effects and safety of proximal femur bionic nail versus proximal femoral nail anti-rotation and InterTAN for the treatment of intertrochanteric femoral fracture: a systematic review and meta-analysis
Objective To compare the clinical effects and safety of the proximal femur bionic nail (PFBN) with those of proximal femoral nail anti-rotation (PFNA) and InterTAN for the treatment of intertrochanteric femoral fracture (IFF). Methods Studies comparing the clinical efficacy of PFBN with that of PFNA and InterTAN in the treatment of IFF published before August 2024 in the PubMed, Embase, Web of Science, Cochrane, CNKI, Wanfang, and VIP databases were retrieved. After the research data were extracted, Review Manager 5.4 (RevMan 5.4) was used for data analysis. Results A total of 13 studies involving 825 patients were included. The meta-analysis results indicated that the PFBN group had advantages over the control group in terms of the postoperative partial and full weight-bearing time, fracture healing time, fracture reduction quality, hospital stay, visual analog scale (VAS) score, and postoperative complication rate (partial weight-bearing time: standardized mean difference (SMD) = -3.06, 95% confidence interval (CI) -4.02~-2.09, P < 0.00001; full weight-bearing time: SMD = -1.78, 95% CI -2.86~-0.70, P = 0.001; fracture healing time: SMD = -0.55, 95% CI -0.82~-0.28, P < 0.0001; fracture reduction quality: relative risk (RR) = 1.07, 95% CI 1.01 ~ 1.13, P = 0.02; hospital stay: SMD = -0.16, 95% CI -0.33 ~ 0.00, P = 0.05; postoperative VAS score: SMD = -0.54, 95% CI -0.90~-0.18, P = 0.003; postoperative complication rate: RR = 0.36, 95% CI 0.21 ~ 0.61, P = 0.0001). There was no significant difference between the two groups in terms of intraoperative blood loss, operation duration, postoperative hip range of motion, postoperative Harris score, intraoperative fluoroscopy time, or incision length (intraoperative blood loss: SMD = -0.57, 95% CI -1.16 ~ 0.02, P = 0.06; operation duration: SMD = 0.28, 95% CI -0.20 ~ 0.76, P = 0.26; postoperative flexion and extension motion: SMD = 0.28, 95% CI -0.18 ~ 0.73, P = 0.23; postoperative rotational motion: SMD = 0.20, 95% CI -0.25 ~ 0.66, P = 0.38; postoperative Harris score: SMD = 0.32, 95% CI 0.00 ~ 0.64, P = 0.05; intraoperative fluoroscopy time: SMD = 0.84, 95% CI -0.24 ~ 1.92, P = 0.13; incision length: SMD = 0.23, 95% CI -0.44 ~ 0.89, P = 0.50). Conclusion For the treatment of IFF, the PFBN is more effective and has a lower risk than the PFNA and InterTAN.
- Open Access
- 23 August 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 1-10
The role of scapular morphological structure in degenerative rotator cuff injury: a digital reconstruction radiograph study
To investigate the relationships among the acromial tilt (AT), the glenoid inclination angle (GIA), the critical shoulder angle (CSA), the acromioglenoid angle (AGA), and degenerative rotator cuff injury via digital reconstruction radiographs (DRRs). A retrospective cohort of 63 patients who met the inclusion criteria were enrolled from the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine between April 2023 and April 2024, 33 patients with rotator cuff injury and 30 controls were included. Clinical data and scapular computed tomography (CT) scans were collected, and three-dimensional reconstructions were generated via Amira software (Thermo Fisher Scientific, USA). Digital reconstruction radiograph (DRR) images were simulated at the Grashey and Y positions of the scapula, and the parameters were measured via Digimizer software (MedCalc Software, Belgium). The diagnostic and predictive validity of each parameter for DRR for rotator cuff injury was assessed through statistical analysis of the measured data, including inter-observer consistency, correlation analysis among parameters, and receiver operating characteristic (ROC) curve analysis. (1) Inter-observer reliability was excellent for all the parameters (intra-class correlation coefficient (ICC) > 0.8). (2) CSA and AGA were significantly greater in the rotator cuff injury group (PCSA= 0.003;PAGA < 0.001), whereas GIA was significantly lower (P < 0.001); no difference was detected in AT (P > 0.05). (3) Binary logistic regression analysis revealed that GIA, CSA, and AGA were risk factors for rotator cuff injury (PCSA=0.008; PAGA = 0.001; PGIA = 0.001). (4) ROC analysis yielded area under the curve (AUC) values of 0.755 (GIA), 0.700 (CSA), and 0.796 (AGA), with cutoff thresholds of 83.98°, 30.67°, and 42.04°, respectively. (5) Strong correlations were observed between the CSA and AGA (r = 0.939), whereas the GIA was inversely correlated with both the CSA (r = -0.423) and the AGA (r = -0.471). Measurements of GIA, CSA, and AGA derived from DRRs demonstrate high diagnostic value for degenerative rotator cuff injury. DRR represents a reliable alternative to conventional radiography in clinical practice. In the future, DRR holds promise as a tool for assessing the impact of degenerative rotator cuff injury. However, due to radiation exposure concerns, the current application of DRR is recommended primarily for retrospective studies utilizing existing computed tomography (CT) data.
- 23 August 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 1-10
Open AccessThe role of scapular morphological structure in degenerative rotator cuff injury: a digital reconstruction radiograph study
To investigate the relationships among the acromial tilt (AT), the glenoid inclination angle (GIA), the critical shoulder angle (CSA), the acromioglenoid angle (AGA), and degenerative rotator cuff injury via digital reconstruction radiographs (DRRs). A retrospective cohort of 63 patients who met the inclusion criteria were enrolled from the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine between April 2023 and April 2024, 33 patients with rotator cuff injury and 30 controls were included. Clinical data and scapular computed tomography (CT) scans were collected, and three-dimensional reconstructions were generated via Amira software (Thermo Fisher Scientific, USA). Digital reconstruction radiograph (DRR) images were simulated at the Grashey and Y positions of the scapula, and the parameters were measured via Digimizer software (MedCalc Software, Belgium). The diagnostic and predictive validity of each parameter for DRR for rotator cuff injury was assessed through statistical analysis of the measured data, including inter-observer consistency, correlation analysis among parameters, and receiver operating characteristic (ROC) curve analysis. (1) Inter-observer reliability was excellent for all the parameters (intra-class correlation coefficient (ICC) > 0.8). (2) CSA and AGA were significantly greater in the rotator cuff injury group (PCSA= 0.003;PAGA < 0.001), whereas GIA was significantly lower (P < 0.001); no difference was detected in AT (P > 0.05). (3) Binary logistic regression analysis revealed that GIA, CSA, and AGA were risk factors for rotator cuff injury (PCSA=0.008; PAGA = 0.001; PGIA = 0.001). (4) ROC analysis yielded area under the curve (AUC) values of 0.755 (GIA), 0.700 (CSA), and 0.796 (AGA), with cutoff thresholds of 83.98°, 30.67°, and 42.04°, respectively. (5) Strong correlations were observed between the CSA and AGA (r = 0.939), whereas the GIA was inversely correlated with both the CSA (r = -0.423) and the AGA (r = -0.471). Measurements of GIA, CSA, and AGA derived from DRRs demonstrate high diagnostic value for degenerative rotator cuff injury. DRR represents a reliable alternative to conventional radiography in clinical practice. In the future, DRR holds promise as a tool for assessing the impact of degenerative rotator cuff injury. However, due to radiation exposure concerns, the current application of DRR is recommended primarily for retrospective studies utilizing existing computed tomography (CT) data.
- Open Access
- 1 November 2024
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 25 (1) , 1-19
Efficacy and safety of high tibial osteotomy combined with platelet-rich plasma for treating knee osteoarthritis: a systematic review and meta-analysis of the Chinese population
To systematically review the clinical efficacy and safety of high tibial osteotomy (HTO) combined with platelet-rich plasma (PRP) for treating knee osteoarthritis (KOA) and to provide evidence of the effectiveness of evidence-based medicine for treating this disease. Clinical studies on the use of HTO combined with PRP for the treatment of KOA before September 2024 were identified. The literature that met the inclusion criteria was strictly screened out, the literature information was extracted, and the data were input into RevMan5.4 for analysis. Ten studies (12 controls) with 625 patients were included. Overall, the visual analog scale (VAS) score (mean difference (MD) = -0.53, 95% confidence interval (CI) (-0.76, -0.31), P < 0.00001), range of motion (ROM) (MD = 7.24, 95% CI (2.79, 11.69), P = 0.001), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score (MD = -6.91, 95% CI (-9.47, -4.34), P < 0.00001), cartilage recovery (cartilage thickness: MD = 0.43, 95% CI (0.35, 0.51), P < 0.00001; cartilage regeneration: relative risk (RR) = 1.81, 95% CI (1.40, 2.33), P < 0.00001; and the International Cartilage Repair Society (ICRS) grade: RR = 1.96, 95% CI (1.44, 2.66), P < 0.0001), and the Lysholm score (MD = 6.51, 95% CI (4.97, 8.04), P < 0.00001) after HTO-PRP treatment had certain advantages compared to the control group. After treatment, there was no statistically significant difference in the knee joint mechanical axis angle between the HTO-PRP group and the control group (femoral tibial angle (FTA): MD = -0.29, 95% CI (-1.07, 0.49), P = 0.47; medial proximal tibial angle (MPTA): MD = 0.19, 95% CI (-0.49, 0.88), P = 0.58; posterior tibial slope (PTS): MD = -0.12, 95% CI (-0.49, 0.25), P = 0.53; knee varus angle (KVA): MD = -0.30, 95% CI (-1.77, 1.17), P = 0.69; weight-bearing line (WBL): MD = 1.10, 95% CI (-0.89, 3.09), P = 0.28). The results showed that in the treatment of KOA, the HTO-PRP group had better efficacy than the control groups did and had certain safety reliability.
- 1 November 2024
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 25 (1) , 1-19
Open AccessEfficacy and safety of high tibial osteotomy combined with platelet-rich plasma for treating knee osteoarthritis: a systematic review and meta-analysis of the Chinese population
To systematically review the clinical efficacy and safety of high tibial osteotomy (HTO) combined with platelet-rich plasma (PRP) for treating knee osteoarthritis (KOA) and to provide evidence of the effectiveness of evidence-based medicine for treating this disease. Clinical studies on the use of HTO combined with PRP for the treatment of KOA before September 2024 were identified. The literature that met the inclusion criteria was strictly screened out, the literature information was extracted, and the data were input into RevMan5.4 for analysis. Ten studies (12 controls) with 625 patients were included. Overall, the visual analog scale (VAS) score (mean difference (MD) = -0.53, 95% confidence interval (CI) (-0.76, -0.31), P < 0.00001), range of motion (ROM) (MD = 7.24, 95% CI (2.79, 11.69), P = 0.001), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score (MD = -6.91, 95% CI (-9.47, -4.34), P < 0.00001), cartilage recovery (cartilage thickness: MD = 0.43, 95% CI (0.35, 0.51), P < 0.00001; cartilage regeneration: relative risk (RR) = 1.81, 95% CI (1.40, 2.33), P < 0.00001; and the International Cartilage Repair Society (ICRS) grade: RR = 1.96, 95% CI (1.44, 2.66), P < 0.0001), and the Lysholm score (MD = 6.51, 95% CI (4.97, 8.04), P < 0.00001) after HTO-PRP treatment had certain advantages compared to the control group. After treatment, there was no statistically significant difference in the knee joint mechanical axis angle between the HTO-PRP group and the control group (femoral tibial angle (FTA): MD = -0.29, 95% CI (-1.07, 0.49), P = 0.47; medial proximal tibial angle (MPTA): MD = 0.19, 95% CI (-0.49, 0.88), P = 0.58; posterior tibial slope (PTS): MD = -0.12, 95% CI (-0.49, 0.25), P = 0.53; knee varus angle (KVA): MD = -0.30, 95% CI (-1.77, 1.17), P = 0.69; weight-bearing line (WBL): MD = 1.10, 95% CI (-0.89, 3.09), P = 0.28). The results showed that in the treatment of KOA, the HTO-PRP group had better efficacy than the control groups did and had certain safety reliability.